ifosfamide has been researched along with Leukoencephalopathy, Progressive Multifocal in 1 studies
Leukoencephalopathy, Progressive Multifocal: An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study describes a 36-year-old woman with primary refractory T-cell lymphoma, who developed central nervous system toxicity due to treatment with intrathecal methotrexate and intravenous ifosfamide, idarubicine and etoposide given as a salvage regimen." | 3.73 | Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma. ( Abali, H; Dizdar, O; Erdem, I; Eren, OO; Erman, M; Karadağ, O; Türker, A; Uluç, K; Yilmaz, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abali, H | 1 |
| Eren, OO | 1 |
| Dizdar, O | 1 |
| Karadağ, O | 1 |
| Erman, M | 1 |
| Yilmaz, A | 1 |
| Uluç, K | 1 |
| Erdem, I | 1 |
| Türker, A | 1 |
1 other study available for ifosfamide and Leukoencephalopathy, Progressive Multifocal
| Article | Year |
|---|---|
Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Etoposide; Fatal Outcome; Female; Hem | 2005 |